Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model
暂无分享,去创建一个
M. Lerner | A. Richardson | M. Zalles | N. Smith | D. Saunders | Rafał Gulej | R. Towner | K. Morton | Rafal Gulej
[1] M. Mattson,et al. Age-related impairment of cerebral blood flow response to KATP channel opener in Alzheimer’s disease mice with presenilin-1 mutation , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] Xin Yi,et al. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis. , 2020, Life sciences.
[3] B. Miller,et al. Molecular changes associated with spinal cord aging , 2020, GeroScience.
[4] K. Sataranatarajan,et al. Molecular changes associated with spinal cord aging , 2020, GeroScience.
[5] Zhenhong Wei,et al. Perturbation of Ephrin Receptor Signaling and Glutamatergic Transmission in the Hypothalamus in Depression Using Proteomics Integrated With Metabolomics , 2019, Front. Neurosci..
[6] M. Henkemeyer,et al. EphB2 receptor cell-autonomous forward signaling mediates auditory memory recall and learning-driven spinogenesis , 2019, Communications Biology.
[7] N. Smith,et al. Anti-inflammatory agent, OKN-007, reverses long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation , 2019, GeroScience.
[8] Ji-xian Wang,et al. Rapamycin Increases Collateral Circulation in Rodent Brain after Focal Ischemia as detected by Multiple Modality Dynamic Imaging , 2019, Theranostics.
[9] T. Sargeant,et al. Rapamycin and Alzheimer disease: a double-edged sword? , 2019, Autophagy.
[10] W. Yao,et al. Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses , 2019, Acta Pharmacologica Sinica.
[11] Chao Ma,et al. Rapamycin regulates cholesterol biosynthesis and cytoplasmic ribosomal proteins in hippocampus and temporal lobe of APP/PS1 mouse , 2019, Journal of the Neurological Sciences.
[12] Wei Bi,et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice , 2019, Scientific Reports.
[13] E. Wang,et al. 1H-MRS Quantitation of Age-Dependent Taurine Changes in Mouse Brain , 2019, Molecular Imaging and Biology.
[14] S. Rizvi,et al. Rapamycin Confers Neuroprotection Against Aging-Induced Oxidative Stress, Mitochondrial Dysfunction, and Neurodegeneration in Old Rats Through Activation of Autophagy. , 2019, Rejuvenation research.
[15] M. V. Tenditnik,et al. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease , 2019, Pharmacology Biochemistry and Behavior.
[16] E. Aronica,et al. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo — in search of potential anti-epileptogenic strategies for temporal lobe epilepsy , 2018, Journal of Neuroinflammation.
[17] Cai-Hong Yang,et al. Effects of long-term rapamycin treatment on glial scar formation after cryogenic traumatic brain injury in mice , 2018, Neuroscience Letters.
[18] M. Lerner,et al. Assessing long-term neuroinflammatory responses to encephalopathy using MRI approaches in a rat endotoxemia model , 2018, GeroScience.
[19] S. Green,et al. Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome , 2017, Front. Aging Neurosci..
[20] M. Fang,et al. The post‐therapeutic effect of rapamycin in mild traumatic brain‐injured rats ensuing in the upregulation of autophagy and mitophagy , 2017, Cell biology international.
[21] H. Weiss,et al. Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia , 2017, Neuroscience Letters.
[22] Ying-chun Liu,et al. Rapamycin suppresses Aβ25–35- or LPS-induced neuronal inflammation via modulation of NF-κB signaling , 2017, Neuroscience.
[23] Wang-Tso Lee,et al. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures , 2017, Journal of Neuroinflammation.
[24] Yiyu Deng,et al. Rapamycin inhibits lipopolysaccharide-induced neuroinflammation in vitro and in vivo , 2016, Molecular medicine reports.
[25] H. Zhang,et al. Rapamycin protects against neuronal death and improves neurological function with modulation of microglia after experimental intracerebral hemorrhage in rats. , 2016, Cellular and molecular biology.
[26] Kathleen F. Kerr,et al. Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice , 2016, eLife.
[27] H. Weiss,et al. Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion , 2016, Neuroscience Letters.
[28] M. Greenberg,et al. EphB1 and EphB2 intracellular domains regulate the formation of the corpus callosum and anterior commissure , 2016, Developmental neurobiology.
[29] Dong-Hyun Kim,et al. Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice , 2016, BMC Microbiology.
[30] E. Aronica,et al. Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats II: Potential mechanisms , 2016, Epilepsia.
[31] E. Aronica,et al. Blood–brain barrier leakage after status epilepticus in rapamycin‐treated rats I: Magnetic resonance imaging , 2016, Epilepsia.
[32] Wei Zhang,et al. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[33] Qi-min Song,et al. Rapamycin protects neurons from brain contusion-induced inflammatory reaction via modulation of microglial activation , 2015, Molecular medicine reports.
[34] Y. Gupta,et al. Rapamycin ameliorates brain metabolites alterations after transient focal ischemia in rats. , 2015, European journal of pharmacology.
[35] Lin Zhu,et al. Rapamycin protects against apoptotic neuronal death and improves neurologic function after traumatic brain injury in mice via modulation of the mTOR-p53-Bax axis. , 2015, The Journal of surgical research.
[36] A. Constanti,et al. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release , 2014, Brain, Behavior, and Immunity.
[37] C. Franceschi,et al. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[38] K. Khalili,et al. TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2 , 2014, Journal of Neuroimmune Pharmacology.
[39] M. Ono,et al. A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathy , 2013, Journal of Neuroinflammation.
[40] P. Fox,et al. Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] M. Blagosklonny,et al. Rapamycin suppresses brain aging in senescence-accelerated OXYS rats , 2013, Aging.
[42] Stephanie D. Kraft-Terry,et al. Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain , 2013, Journal of Neuroimmune Pharmacology.
[43] Maria A. Woodward,et al. Rapamycin slows aging in mice , 2012, Aging cell.
[44] Eleonora Aronica,et al. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood–brain barrier leakage but not microglia activation , 2012, Epilepsia.
[45] Phil Lee,et al. Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice , 2012, Experimental Neurology.
[46] M. Hall,et al. Rapamycin passes the torch: a new generation of mTOR inhibitors , 2011, Nature Reviews Drug Discovery.
[47] R. D'Agostino,et al. Aging masks detection of radiation-induced brain injury , 2011, Brain Research.
[48] B. Carnes,et al. Basal and hypercapnia-altered cerebrovascular perfusion predict mild cognitive impairment in aging rodents , 2009, Neuroscience.
[49] Pierluigi Navarra,et al. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. , 2009, Biochemical pharmacology.
[50] Peter Jezzard,et al. Comparison of hypercapnia‐based calibration techniques for measurement of cerebral oxygen metabolism with MRI , 2009, Magnetic resonance in medicine.
[51] D. Sretavan,et al. Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss. , 2007, Investigative ophthalmology & visual science.
[52] Michelle N. Ngo,et al. Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus , 2003, The Journal of cell biology.
[53] G. Crelier,et al. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: The deoxyhemoglobin dilution model , 1999, Magnetic resonance in medicine.
[54] Elena B. Pasquale,et al. The Eph family: a multitude of receptors that mediate cell recognition signals , 1997, Cell and Tissue Research.
[55] E. London,et al. Regional cerebral blood flow during development and ageing of the rat brain. , 1981, Brain : a journal of neurology.
[56] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .